FDA grants accelerated approval to umbralisib for marginal zone lymphoma and follicular lymphoma
On February 5, 2021, the Food and Drug Administration granted accelerated approval to umbralisib, a…
Browsing: umbralisib
Trending
- Making Telehealth Human – Podcast
- Sign Up for The Oncology Newsletter | Our free weekly news roundup
- Antihypertensives can decrease bleomycin-induced lung injury
- How women make choices about surgery to prevent ovarian cancer
- Cell-free DNA in urine potential method for cancer detection
- Physical conditions linked to psychological distress in patients with cancer
- An efficient method for separating O-18 from O-16, essential for use in cancer treatment
- CAR T therapy shows long-lasting remissions in non-hodgkin lymphoma
- Predictions for cancer deaths in EU & UK in 2021: How will COVID affect death rates?
- Acid reflux disease may increase risk of cancers of the larynx and oesophagus
